Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 05:17
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 105°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
Ú¸ °¡À̵å¶óÀÎ, ¹» ³ë·È³ª?
ÀÌ»óµ· ±âÀÚ
2020-11-02 17:15
[Sub Story]
´ëÇѹα¹ÀÌ Á¤ÀÇÇÑ °íÇ÷¾ÐÀº?
ÀÌ»óµ· ±âÀÚ
2020-11-02 16:46
[Sub Story]
³·¾ÆÁø ¸ñÇ¥Ç÷¾Ð,
¡®Á¶Àý·ü °³¼±¡¯ °úÁ¦·Î µ¹¾Æ¿À´Ù
ÀÓ¼¼Çü ±âÀÚ
2020-11-02 16:42
[Sub Story]
¡°°íÇ÷¾Ð Ä¡·á Àü¹Ý¿¡ 130/80mmHg ¹Ì¸¸¡±
ÀÌ»óµ· ±âÀÚ
2020-11-02 15:58
[Sub Story]
´Ù¾ç¡¤¹Ýº¹ Ç÷¾ÐÃøÁ¤ 24½Ã°£ Ç÷¾ÐÁ¶Àý
ÀÌ»óµ· ±âÀÚ
2020-11-02 15:38
¶óÀÎ
[Sub Story]
¹Ì¡¤À¯·´ °íÇ÷¾Ð °¡À̵å Àû¿ëÇϸ顦
ÀÌ»óµ· ±âÀÚ
2020-11-02 14:42
[Late Breaking Studies]
Ä¡¸Å¿¡ ´øÁö´Â µÎ °¡Áö Áú¹®
ÀÌ»óµ· ±âÀÚ
2020-09-29 13:19
[Sub Story]
[½ÉºÎÀü ȯÀÚ¿¡¼ Ç×°íÇ÷¾ÐÁ¦ »ç¿ë Àü·«]
¡®½ÉºÎÀü ¾àÁ¦¡¯·Î¼ÀÇ Ç×°íÇ÷¾ÐÁ¦ ÀÎ½Ä ÇÊ¿ä
THE MOST
2020-08-13 14:37
[Sub Story]
CAD µ¿¹Ý °íÇ÷¾Ð, 130/80mmHg ¹Ì¸¸À¸·Î Á¶Àý
ÀÌ»óµ· ±âÀÚ
2020-05-12 17:43
[Sub Story]
Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ý SPRINT Ÿ°í Äè¼ÓÁúÁÖ
ÀÌ»óµ· ±âÀÚ
2020-05-12 17:42
¶óÀÎ
[Sub Story]
´Ù¾çÇÑ Ç÷¾ÐÃøÁ¤ ¹Ýº¹À¸·Î º¯µ¿¼º °É·¯³»¾ß
ÀÌ»óµ· ±âÀÚ
2020-05-12 15:58
[Late Breaking Studies]
ĵ¥»ç¸£Åº, ¾Æħ°íÇ÷¾Ð¡¤½ÉºÎÀü ȯÀÚ °ü¸®¿¡ È¿°ú º¸°í
ÀÓ¼¼Çü ±âÀÚ
2020-05-12 11:50
[Drug Review]
S-¾Ï·ÎµðÇÉ, ÇÏÁöºÎÁ¾ À§Çè ³·Ãá Àå±âÀÛ¿ë CCB
ÀÓ¼¼Çü ±âÀÚ
2020-05-12 11:42
[Sub Story]
½É±Ù°æ»öÁõ Ç÷¾Ð, 120/70mmHg ¹Ì¸¸ ±Ç°íµÇÁö ¾Ê¾Æ
THE MOST
2020-01-30 16:17
[Conference Report]
ÃÖÀû Ç÷¾ÐÄ¡·á »õ ±âÁØ Á¦½Ã
ÀÌ»óµ· ±âÀÚ
2020-01-30 10:50
¶óÀÎ
[Sub Story]
Ç÷¾Ð ´õ ³·Ãß·Á¸é, Ç×°íÇ÷¾ÐÁ¦ ´õ ÇÊ¿äÇÏ´Ù
ÀÌ»óµ· ±âÀÚ
2020-01-02 17:09
[Cover Story]
°íÇ÷¾Ð Ä¡·áÀÇ »õ Æз¯´ÙÀÓ
ÀÌ»óµ· ±âÀÚ
2020-01-02 17:09
[Sub Story]
Ú¸ °¡À̵å¶óÀÎ µû¶ó°¡¸é¡¦
ÀÌ»óµ· ±âÀÚ
2020-01-02 17:02
[Sub Story]
°íÇ÷¾Ð¿¡¼ Ä¡¸Å±îÁö
ÀÌ»óµ· ±âÀÚ
2020-01-02 15:27
[Sub Story]
Ç×°íÇ÷¾ÐÄ¡·á, Ä¡¸Å¡¤ÀÎÁö±â´É °³¼±±îÁö ±â´ë
ÀÌ»óµ· ±âÀÚ
2020-01-02 15:22
-
1
2
3
4
5
6
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top